PETSNasdaqRetail-Drug Stores and Proprietary StoresUS GAAP · USD

PetMed Express, Inc

PetMed Express is a U.S.-based direct-to-consumer pet pharmacy and pet health retailer operating through the PetMeds and PetCareRx brands. It sells prescription and non-prescription pet medications, wellness products, food, and related services through its websites, mobile apps, and customer contact center, with fulfillment centered in the United States.

Revenue179m USD
−21.1 %y/y
Operating profit (EBIT)-58.7m USD
−3,734.8 %y/y
EBIT margin-32.8%
−32.1 ppy/y
Net income-57.3m USD
−813.5 %y/y
Free cash flow-33.0m USD
−8,256.7 %y/y

Fiscal year 2026 · change from previous year

Development 2021–2026

-1000100200300400m USD2021: 309 m USD2021: EBIT 31 m USD20212022: 273 m USD2022: EBIT 26 m USD20222023: 248 m USD2023: EBIT 6.1 m USD20232024: 274 m USD2024: EBIT -8.2 m USD20242025: 227 m USD2025: EBIT -1.5 m USD20252026: 179 m USD2026: EBIT -59 m USD2026179-59
RevenueOperating profit (EBIT)

Business

Share of revenue
Prescription medications45 %

Branded, generic, and compounded pet prescription drugs dispensed through licensed pharmacies.

Non-prescription health products25 %

OTC supplements, flea and tick preventatives, vitamins, shampoos, and hygiene items.

Pet food and nutrition15 %

Premium pet foods, treats, and veterinary prescription diets.

Pharmacy services and fulfillment10 %

Order verification, prescription handling, shipping, autoship, and customer support.

Private label products5 %

Exclusive branded pet wellness products sold across direct and partner channels.

Customers

PetMed Express sells mainly to retail pet owners who buy medications, food, and wellness products for dogs, cats, and horses. Its customers are typically looking for convenience, price comparison, home delivery, and help managing recurring or chronic pet conditions. The business also depends on veterinarians because prescriptions must be verified before many products can be dispensed.

Retail pet owners

Households buying pet medications, food, and supplies for home delivery and convenience

Chronic-condition pet patients

Owners refilling treatments for allergies, arthritis, anxiety, thyroid, and similar conditions

Autoship and repeat buyers

Customers using recurring delivery for maintenance medications and consumables

Veterinarian-referred prescription customers

Pet owners whose orders require veterinarian approval before dispensing

Strategy

PetMed Express is expanding from a digital-only pharmacy model toward a broader omnichannel pet health platform. Its priorities include adding marketplace and retail-channel reach, expanding compound pharmacy partnerships, introducing private-label products, and modernizing e-commerce and cloud infrastructure to improve customer acquisition, retention, and fulfillment speed.

Omnichannel expansionMedium term

Broader channel access can reduce reliance on owned web traffic and widen customer reach.

Private label developmentMedium term

Exclusive products can strengthen brand loyalty and create differentiation versus commodity pet retail.

Pharmacy and service partnershipsShort term

Compound and veterinary service partnerships extend the addressable pet-health offering.

Technology and fulfillment modernizationShort term

Better digital infrastructure and faster delivery support conversion and repeat purchasing.

Geography

The company serves customers throughout the United States and operates as a nationwide online retailer rather than a store-based chain. Its headquarters are in Delray Beach, Florida, and it relies on U.S.-based pharmacy and distribution locations, including a primary distribution center in South Florida and a PetCareRx distribution center in New York. Customer concentration is broad, though several large states account for a meaningful share of the customer base.

Risks

The business depends on regulatory compliance, especially for dispensing prescription pet medications and maintaining pharmacy licenses. It is also exposed to demand concentration in online retail, customer acquisition costs, fulfillment interruptions, and goodwill or intangible asset impairment if operating performance weakens.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Pharmacy regulation and licensing1Fulfillment and business interruption2Acquisition-related and intangible asset risk3
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Pharmacy regulation and licensingImpact: HighLikelihood: Medium

    Prescription pet medications are dispensed under state and federal rules, so noncompliance can trigger sanctions or license loss.

    Exposure: Prescription dispensing and pharmacy operations

  2. Fulfillment and business interruptionImpact: HighLikelihood: Low

    Operations rely on concentrated distribution locations, making the company vulnerable to outages, fires, floods, or equipment failures.

    Exposure: South Florida and New York distribution sites

  3. Acquisition-related and intangible asset riskImpact: HighLikelihood: Low

    The company recorded goodwill and other acquired assets that can be impaired if forecasts or market value decline.

    Exposure: PetCareRx acquisition and reporting unit valuation

  4. Customer acquisition and digital traffic dependenceImpact: Medium

    The model relies on national advertising and online conversion, so weaker traffic or higher marketing costs can pressure growth.

    Exposure: Owned websites and mobile apps

  5. Unsolicited acquisition proposals or control contestsImpact: Medium

    These events can distract management, create legal costs, and unsettle customers or suppliers.

    Exposure: Corporate governance and stock volatility

Accounting

Judgemental items
Point-in-time revenue recognition

Sales are recognized when shipment occurs, so order timing and shipping cutoffs affect quarterly revenue.

Impact: Net sales and quarterly comparability

Returns reserve

Management estimates product returns using historical patterns, which affects reported revenue.

Impact: Net sales and gross margin

Outbound shipping accounting

Shipping and handling fees are included in sales and fulfillment costs are expensed in cost of sales.

Impact: Revenue presentation and margin ratios

Goodwill impairment testing

The company recorded a full goodwill impairment charge after revising forecasts and using discounted cash flow valuation.

Impact: Noncash operating results and balance sheet carrying value

Inventory and bad debt estimates

Pet pharmacy and retail inventory require judgment on obsolescence, demand, and collectability.

Impact: Cost of sales and operating expenses

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026